AGL 38.15 Increased By ▲ 0.90 (2.42%)
AIRLINK 121.51 Decreased By ▼ -2.51 (-2.02%)
BOP 5.85 Increased By ▲ 0.23 (4.09%)
CNERGY 3.75 Increased By ▲ 0.03 (0.81%)
DCL 8.40 Increased By ▲ 0.15 (1.82%)
DFML 40.89 Increased By ▲ 0.62 (1.54%)
DGKC 84.60 Decreased By ▼ -1.14 (-1.33%)
FCCL 32.70 Increased By ▲ 0.10 (0.31%)
FFBL 65.50 Decreased By ▼ -1.00 (-1.5%)
FFL 10.05 Decreased By ▼ -0.11 (-1.08%)
HUBC 103.80 Increased By ▲ 0.70 (0.68%)
HUMNL 13.25 Decreased By ▼ -0.15 (-1.12%)
KEL 4.43 Increased By ▲ 0.18 (4.24%)
KOSM 7.09 Decreased By ▼ -0.09 (-1.25%)
MLCF 37.50 Decreased By ▼ -0.80 (-2.09%)
NBP 60.25 Decreased By ▼ -4.76 (-7.32%)
OGDC 172.25 Decreased By ▼ -1.55 (-0.89%)
PAEL 24.80 Decreased By ▼ -0.10 (-0.4%)
PIBTL 5.70 Decreased By ▼ -0.10 (-1.72%)
PPL 141.69 Decreased By ▼ -1.01 (-0.71%)
PRL 22.72 Decreased By ▼ -0.26 (-1.13%)
PTC 14.74 Decreased By ▼ -0.37 (-2.45%)
SEARL 64.56 Decreased By ▼ -0.79 (-1.21%)
TELE 7.14 Increased By ▲ 0.14 (2%)
TOMCL 35.50 Decreased By ▼ -1.41 (-3.82%)
TPLP 7.29 Decreased By ▼ -0.05 (-0.68%)
TREET 14.20 Decreased By ▼ -0.08 (-0.56%)
TRG 51.75 Increased By ▲ 2.05 (4.12%)
UNITY 26.60 Increased By ▲ 0.45 (1.72%)
WTL 1.22 Decreased By ▼ -0.02 (-1.61%)
BR100 9,483 Decreased By -118.3 (-1.23%)
BR30 28,371 Decreased By -202.1 (-0.71%)
KSE100 88,967 Decreased By -1319.8 (-1.46%)
KSE30 27,827 Decreased By -515.9 (-1.82%)

Drugmakers Merck and GlaxoSmithKline have cut the price of cervical cancer shots in a deal that will deliver them to poor countries for less than $5 a dose. The new record low price for human papillomavirus (HPV) vaccines should mean millions of girls in developing countries can be protected against the disease, the Global Alliance for Vaccines and Immunisations (GAVI) said on Thursday.
"By 2020 we hope to reach more than 30 million girls in more than 40 countries," Seth Berkley, the group's chief executive, said in a statement announcing the price deal. More than 85 percent of cervical cancer deaths are in poorer countries and globally, 275,000 women a year die of the disease. That means it kills more women world-wide than childbirth, according to GAVI, claiming a life every two minutes. GAVI, a non-profit group that funds bulk-buy vaccine programmes for poor countries, will deliver the cut-price shots.
It said in February that Ghana, Kenya, Laos, Madagascar, Malawi, Niger, Sierra Leone and Tanzania would be the first countries to get support in pilot projects. The vaccines - Merck's Gardasil and GSK's Cervarix - can cost more than $100 in developed countries and have been introduced in immunisation campaigns in rich regions like the United States and Europe in recent years.
They are generally given to girls aged around eight or nine and over to protect them against the human papillomavirus that causes almost all cervical cancers. A study published in 2011 found that since 1980, new cervical cancer cases and deaths have dropped substantially in rich countries - mostly due to better screening and earlier detection - but increased sharply in poor regions. Sub-Saharan Africa has 22 percent of all cervical cancer cases world-wide.

Copyright Reuters, 2013

Comments

Comments are closed.